Roche's Tecentriq wins FDA approval for treating advanced bladder cancer – Reuters
Reuters |
Roche’s Tecentriq wins FDA approval for treating advanced bladder cancer
Reuters A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo. Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. … Roche’s (RHHBY) Genentech Granted FDA Accelerated Approval for TECENTRIQ |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.